Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 May;8(5):1447-53.
doi: 10.1002/j.1460-2075.1989.tb03527.x.

The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites

Affiliations

The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites

G Urier et al. EMBO J. 1989 May.

Abstract

When expressed in Epstein-Barr virus (EBV) latently infected B cells, the EBV early protein EB1 trans-activates as many EBV early genes as does TPA. Several EB1 responsive elements (ZRE) have been identified in EBV early promoters and are located at relatively short distances from the TATA box. One of them (ZRE-M) overlaps with a consensus TPA responsive element (TRE) defined as an AP-1/c-jun/c-fos binding site and is located in an EBV promoter controlling the expression of the post-transcriptional activator EB2. Another (ZREZ) is located in the promoter controlling the expression of EB1 and does not respond to TPA. These two ZREs have no apparent sequence homology. Although EB1 activates transcription from the AP-1 enhancer sequence and from the ZREZ, the activation is severely impaired by distance, suggesting that EB1 is more likely to be a promoter factor than an enhancer factor. These properties also suggest that EB1 is not functionally related to c-jun and c-fos. However, since EB1 can activate transcription from AP-1 binding sites when properly positioned, the role of this factor in the oncogenic properties of EBV should be considered.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1986 Mar;57(3):1016-22 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4085-9 - PubMed
    1. J Virol. 1986 Oct;60(1):140-8 - PubMed
    1. J Virol. 1986 Oct;60(1):149-56 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6682-6 - PubMed

Publication types

MeSH terms